Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 4—April 2007

Dispatch

Endpoints for Lymphatic Filariasis Programs

Caroline A. Grady*, Madsen Beau de Rochars†, Abdel N. Direny†, Jean Nicolas Orelus†, Joyanna Wendt*, Jeanne Radday*, Els Mathieu*, Jacquelin M. Roberts*, Thomas G. Streit‡, David G. Addiss*, and Patrick J. Lammie*Comments to Author 
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Hopital Ste. Croix, Leogane, Haiti; ‡University of Notre Dame, Notre Dame, Indiana, USA;

Main Article

Figure 1

Microfilaremia prevalence determined by screening thick blood films before and 6–9 months after annual mass drug administration in sentinel sites in Leogane Commune, Haiti. Blood samples (20 μL) were collected from 7–9 PM.

Figure 1. Microfilaremia prevalence determined by screening thick blood films before and 6–9 months after annual mass drug administration in sentinel sites in Leogane Commune, Haiti. Blood samples (20 μL) were collected from 7–9 PM.

Main Article

TOP